Medical Condition News

RSS

Study could help develop drugs for pregnancy maintenance, treat autoimmune diseases

A team of scientists from Immanuel Kant Baltic Federal University with their colleagues from the Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences (Perm) studied the effect of trophoblastic β1-glycoprotein in the blood of pregnant women on pro-inflammatory immune cells.

10 Feb 2021

Study identifies new therapeutic targets for treatment of obesity and type 2 diabetes

The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake.

10 Feb 2021

Virtual reality app can help reduce fear of heights

Researchers from the University of Basel have developed a virtual reality app for smartphones to reduce fear of heights.

10 Feb 2021

Researchers find higher odds of hospital readmission after endovascular aneurysm repair

Ruptured abdominal aortic aneurysms (rAAA) are responsible for nearly 2% of all deaths in U.S. men over the age of 65.

10 Feb 2021

Long-term stress is a risk factor for heart attacks, study suggests

Can long-term stress lead to heart attacks? Most people would probably answer in the affirmative, but the scientific evidence of this is scarce.

10 Feb 2021

Pandemic-fueled alcohol abuse creates wave of hospitalizations for liver disease

As the pandemic sends thousands of recovering alcoholics into relapse, hospitals across the country have reported dramatic increases in alcohol-related admissions for critical diseases like alcoholic hepatitis and liver failure.

10 Feb 2021

Inherited genetic variation may affect the response to cancer immunotherapy

For all their importance as a breakthrough treatment, the cancer immunotherapies known as checkpoint inhibitors still only benefit a small minority of patients, perhaps 15 percent across different types of cancer.

10 Feb 2021

Study unravels function of 'mystery protein' that kills brain cells of people with Parkinson's

A study published in Nature Communications today (Wednesday 10 February) presents compelling new evidence about what a key protein called alpha-synuclein actually does in neurons in the brain.

10 Feb 2021

MD Anderson and Mirati Therapeutics collaborate to expand evaluation of potent KRAS inhibitors

The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.

10 Feb 2021

Study finds increasing death rates from heart disease in young women

A nationwide US study has found increasing death rates from heart disease in women under 65. The research is published in European Heart Journal - Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC).

10 Feb 2021

Reducing obesity may prevent up to half of new type 2 diabetes cases

Reducing the prevalence of obesity may prevent up to half of new Type 2 diabetes cases in the United States, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

10 Feb 2021

Study reveals mechanism behind “Fecal Microbiota Transplantation”

Clostridioides difficile infection (rCDI) occurs in the gut and is caused by the Gram-positive, spore-forming anaerobic bacterium, C. difficile when its spores attach to fecal matter and are transferred from hand to mouth by health care workers.

10 Feb 2021

Lundquist Institute receives grant to evaluate safety, efficacy of compound for treating psychological distress

The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.

10 Feb 2021

Cellular survival after radiation exposure depends on the specific protein behavior

Exposure to radiation can wreak indiscriminate havoc on cells, tissues, and organs. Curiously, however, some tissues are more vulnerable to radiation damage than others.

10 Feb 2021

UIC researchers receive $10.15 million grant to develop treatment for dry eye conditions

Researchers at University of Illinois Chicago have been awarded a five-year, $10.15 million grant to develop a broad-spectrum immunomodulatory eye drop to treat patients with severe dry eye and ocular surface disease due to inflammatory and immune system disorders.

9 Feb 2021

Updated spina bifida guidelines cover care across the entire lifespan

Globally, nearly 300,000 babies are born with neural tube defects including spina bifida (SB) each year.

9 Feb 2021

New drug shows promise in treating pancreatic and breast cancers

ProAgio, a drug developed by Georgia State University biology professor Zhi-Ren Liu and his team, is effective at treating pancreatic cancer and prolonging survival in mice, according to a study published in the journal Cellular and Molecular Gastroenterology and Hepatology.

9 Feb 2021

Direct exposure to deadly fires increases the risk for mental health disorders

In 2018, a faulty electric transmission line ignited the Camp Fire in Northern California, ultimately consuming 239 square miles and several communities, including the town of Paradise, which was 95 percent destroyed. At least 85 people died.

9 Feb 2021

People with dementia found to have significantly increased risk for COVID-19

A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19 - and the risk was higher still for African Americans with dementia.

9 Feb 2021

Metal-containing radiopharmaceuticals could improve access to diagnostic imaging of AD

A team of researchers from the Laboratory of Biophysics at NUST MISIS, Lomonosov Moscow State University and D. Mendeleev University of Chemical Technology of Russia has summarized metal-containing diagnostic agents for positron emission tomography (PET), magnetic resonance imaging (MRI), and single-photon emission computed tomography (SPECT) imaging of Alzheimer's disease (AD).

9 Feb 2021

Medical Condition News

Study could help develop drugs for pregnancy maintenance, treat autoimmune diseases

Study identifies new therapeutic targets for treatment of obesity and type 2 diabetes

Virtual reality app can help reduce fear of heights

Researchers find higher odds of hospital readmission after endovascular aneurysm repair

Long-term stress is a risk factor for heart attacks, study suggests

Pandemic-fueled alcohol abuse creates wave of hospitalizations for liver disease

Inherited genetic variation may affect the response to cancer immunotherapy

Study unravels function of 'mystery protein' that kills brain cells of people with Parkinson's

MD Anderson and Mirati Therapeutics collaborate to expand evaluation of potent KRAS inhibitors

Study finds increasing death rates from heart disease in young women

Reducing obesity may prevent up to half of new type 2 diabetes cases

Study reveals mechanism behind “Fecal Microbiota Transplantation”

Lundquist Institute receives grant to evaluate safety, efficacy of compound for treating psychological distress

Cellular survival after radiation exposure depends on the specific protein behavior

UIC researchers receive $10.15 million grant to develop treatment for dry eye conditions

Updated spina bifida guidelines cover care across the entire lifespan

New drug shows promise in treating pancreatic and breast cancers

Direct exposure to deadly fires increases the risk for mental health disorders

People with dementia found to have significantly increased risk for COVID-19

Metal-containing radiopharmaceuticals could improve access to diagnostic imaging of AD

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News